EMA vs SRE
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Emera Inc. presents a conflicting profile: while it maintains a stable Piotroski F-Score of 4/9 and strong revenue growth, it is plagued by a severe collapse in earnings (-56.9% YoY). The stock is currently trading at a significant premium to both its Graham Number ($40.09) and its growth-based intrinsic value ($17.29). While the company outperforms sector averages in profit margins and ROE, critical liquidity risks are evident in the current and quick ratios. The overall outlook is tempered by a highly bearish technical trend and a dangerously high dividend payout ratio.
SRE shows bearish fundamentals based on deterministic rules. Financial strength is strong (F-Score 7/9). Concerns include weak profitability or high valuation.
Compare Another Pair
Related Comparisons
EMA vs SRE: Head-to-Head Comparison
This page compares Emera Incorporated (EMA) and Sempra (SRE) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.